Chennai, Sept. 17 -- Sun Life Global Solutions (SLGS), the Global Capability Centre and microcosm of the global insurance and asset management leader Sun Life, in a significant step towards combating the surge of diabetes in India, today announced a research collaboration with the Indian Institute of Technology-Madras (IIT-Madras).
This joint initiative will support pioneering research aimed at the early diagnosis and improved clinical management of type 2 diabetes.
The study focuses on Pancreastatin as a novel biomarker and explores 10-12 genetic markers that could predict diabetes risk years in advance, even in children.
The International Diabetes Federation's Diabetes Atlas (2025) reports that, across the globe, 11.1% - or 1 in 9 - of...